<--- Back to Details
First PageDocument Content
Rare diseases / Cystic fibrosis transmembrane conductance regulator / Cystic fibrosis / Genotype / Methylenetetrahydrofolate reductase / Warfarin / Pharmacogenetics / Polymorphism / Mutation / Biology / Health / Genetics
Date: 2013-06-20 10:00:20
Rare diseases
Cystic fibrosis transmembrane conductance regulator
Cystic fibrosis
Genotype
Methylenetetrahydrofolate reductase
Warfarin
Pharmacogenetics
Polymorphism
Mutation
Biology
Health
Genetics

Disorder Ashkenazi Jewish Panel: Bloom Syndrome, Canavan Disease, Familial Dysautonomia,

Add to Reading List

Source URL: wwwn.cdc.gov

Download Document from Source Website

File Size: 86,25 KB

Share Document on Facebook

Similar Documents

DOCX Document

DocID: 1wwhs - View Document

DOCX Document

DocID: 1wv76 - View Document

PDF Document

DocID: 1w4hN - View Document

-Application for Renewal of RDMM Catalyst Grants This application is to be used by the Network’s Scientific Advisory Committee (SAC) to determine as to whether to provide an additional year of funding ($

DocID: 1vceh - View Document

MULTISYSTEMIC RARE DISEASES

DocID: 1v3AN - View Document